Detalhe da pesquisa
1.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Lancet Oncol
; 22(1): 51-65, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33285097
2.
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Lancet
; 394(10212): 1929-1939, 2019 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31590988
3.
TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial.
Lancet Oncol
; 17(2): 212-223, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26727163
4.
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Lancet Oncol
; 16(7): 763-74, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26045340
5.
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.
Lancet Oncol
; 16(3): 328-37, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25701171
6.
[Cardiac tamponade as the first symptom of lung cancer]. / Tamponada serca jako pierwszy objaw raka pluca.
Pneumonol Alergol Pol
; 81(2): 149-53, 2013.
Artigo
em Polonês
| MEDLINE | ID: mdl-23420432
7.
Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma.
Oncol Lett
; 21(6): 449, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33868487
8.
Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer.
Lung Cancer
; 85(3): 420-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24997137